ULK1 phosphorylation of striatin activates protein phosphatase 2A and autophagy.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
28 09 2021
Historique:
received: 28 01 2021
revised: 16 07 2021
accepted: 06 09 2021
entrez: 30 9 2021
pubmed: 1 10 2021
medline: 11 2 2022
Statut: ppublish

Résumé

The evolutionarily conserved ULK1 kinase complex acts as gatekeeper of canonical autophagy and regulates induction of autophagosome biogenesis. To better understand control of ULK1 and analyze whether ULK1 has broader functions that are also linked to the later steps of autophagy, we perform comprehensive phosphoproteomic analyses. Combining in vivo with in vitro data, we identify numerous direct ULK1 target sites within autophagy-relevant proteins that are critical for autophagosome maturation and turnover. In addition, we highlight an intimate crosstalk between ULK1 and several phosphatase complexes. ULK1 is not only a PP2A target but also directly phosphorylates the regulatory PP2A subunit striatin, activating PP2A and serving as positive feedback to promote autophagy-dependent protein turnover. Thus, ULK1 and phosphatase activities are tightly coordinated to robustly regulate protein degradation by autophagy.

Identifiants

pubmed: 34592149
pii: S2211-1247(21)01216-X
doi: 10.1016/j.celrep.2021.109762
pii:
doi:

Substances chimiques

Autophagy-Related Proteins 0
Calmodulin-Binding Proteins 0
Intracellular Signaling Peptides and Proteins 0
Membrane Proteins 0
Nerve Tissue Proteins 0
STRN protein, human 0
Autophagy-Related Protein-1 Homolog EC 2.7.11.1
ULK1 protein, human EC 2.7.11.1
Protein Phosphatase 2 EC 3.1.3.16

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109762

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interest The authors declare no competing interests.

Auteurs

Zehan Hu (Z)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Devanarayanan Siva Sankar (DS)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Bich Vu (B)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Alexandre Leytens (A)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Christine Vionnet (C)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Wenxian Wu (W)

Institute of Molecular Medicine I, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.

Michael Stumpe (M)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Esther Martínez-Martínez (E)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Björn Stork (B)

Institute of Molecular Medicine I, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.

Jörn Dengjel (J)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland. Electronic address: joern.dengjel@unifr.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH